- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2196-3061
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia ; day:19 ; month:4 ; year:2017 ; pages:1-10
Current treatment options in psychiatry ; (19.4.2017), 1-10
- Schlagwort
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Urheber
-
Miyamoto, Seiya
- Beteiligte Personen und Organisationen
-
Wolfgang Fleischhacker, W.
SpringerLink (Online service)
- DOI
-
10.1007/s40501-017-0115-z
- URN
-
urn:nbn:de:1111-201705038609
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Miyamoto, Seiya
- Wolfgang Fleischhacker, W.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly
Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France
What Role for Long-Acting Injectable Antipsychotics in Managing Schizophrenia Spectrum Disorders in Children and Adolescents? A Systematic Review
All-cause mortality risk in long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis
Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness
Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Time to Treatment Discontinuation in German Patients with Schizophrenia: Long-Acting Injectables versus Oral Antipsychotics
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly
Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France
What Role for Long-Acting Injectable Antipsychotics in Managing Schizophrenia Spectrum Disorders in Children and Adolescents? A Systematic Review
All-cause mortality risk in long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis
Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness
Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Time to Treatment Discontinuation in German Patients with Schizophrenia: Long-Acting Injectables versus Oral Antipsychotics
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly
Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France
What Role for Long-Acting Injectable Antipsychotics in Managing Schizophrenia Spectrum Disorders in Children and Adolescents? A Systematic Review
All-cause mortality risk in long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis
Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness
Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis